Summary: Sample size justification is required for all clinical studies. However, to many biomedical and clinical researchers, power and sample size analysis seems like a magic trick of statisticians. In this note, we discuss power and sample size calculations and show that biomedical and clinical investigators play a significant role in making such analyses possible and meaningful. Thus, power analysis is really an interactive process and scientific researchers and statisticians are equal partners in the research enterprise.
Introduction
Sample size justification is required for all clinical studies. Although commercial and online statistical software have been developed to calculate sample sizes, for many biomedical and clinical researchers, the calculation of sample size seems like a magic trick of the statisticians. When their statisticians ask them for information pertaining to sample size calculations, many do not understand why statisticians ask them for such information.
Sample size, or power analysis, should be done at the design stage of a clinical study. In general, such calculations are based on statistical distributions of test statistics pertaining to study hypotheses. For adaptive designs [1] , although sample size may be adjusted according to information accumulated after the study begins, the adjustment plan is pre-specified at the design stage.
Note that for some medical journals, editors often ask authors to calculate power of their completed studies and provide such information in their manuscripts. However, such post-hoc power analysis makes no statistical sense. [2] This is because although outcomes of a real study, along with their associated test statistics, are random quantities in the design stage, they all become non-random once a study is completed and have no probabilistic interpretation. Of course, the information in a completed study can be used for designs of future relevant studies.
As study outcomes are random, what is actually observed after a study is completed may be quite different from what has been proposed in the design. However, this does not mean that the study design is wrong or the study was not executed correctly. For example, suppose X is a standard normal random variable with mean 0 and standard deviation 1. The probability that X > 1.96 or X < -1.96 is 0.05. Thus, although we usually get a value of X within the range -1.96 to 1.96 when sampling X, there is still a 5% chance that X is outside of this range. Thus, when values of X are observed outside of the range, it does not mean that our assumption about the distribution of X is wrong.
• 251 • In this manuscript we discuss sample size and power calculations for continuous outcomes. We give the sample size formulas for one group, two independent groups, and two paired groups. We show how preliminary information can be used to power studies. Our paper can demystify sample size justification for biomedical and clinical researchers.
Sample size for one group
We first consider sample size calculations for one group. Although relatively simpler, it helps illustrate basic steps for sample size calculations.
Consider a continuous outcome X and assume it has a normal distribution (often called bell-shaped distribution) with mean µ and variance H is true, X has a high probability of being close to 0 µ . However, because X is random, it is still possible for X to be far away from 0 µ , although such probabilities are small, especially for large n . The type I error α , a quantity introduced to indicate such an error rate, is the probability that measures the likelihood when X is too far from 0 µ under 0 H . This error rate is typically set at α=0.05 for most studies and at α=0.01 for studies with large sample sizes. Given α, power is the probability that we reject 0 H when 0 H is false. The decision to reject the null is based on the standardized difference between X and 0 µ , or the z -score [3] (2) 
Without loss of generality, we assume 0 1 µ µ > . Note that unlike the hypothesis stated in (1), we must specify a known value for µ under the alternative a H if we wish to quantify our ability to reject 0 H when performing power analysis. Such explicit specification is not needed when we only test the null hypothesis after data is observed.
Given type I error α and a specific 1 µ in a H , we then calculate power, or the probability that (the absolute value of) the standardized difference in (2) exceeds the threshold
By comparing the above with (3), we see that the only difference in (5) is the change of condition from 0 H to a H . The probability is again readily evaluated to yield:
As the above shows, the power,
, is a function of sample size n , type I error α and values of µ specified in the null 0 H and alternative a H . In most clinical research studies, 0 µ and 1 µ are posited to reflect treatment effects. Thus, once α is selected, power is only a function of sample size n , which increases as n grows and approaches 1 as n grows unbounded. Thus, by increasing sample size, we can have more power to reject the null, or ascertaining treatment effect.
However, as increasing sample size implies higher cost for studies, power is generally set at some reasonable level such as 0.80. Also, although we can detect any small treatment effect, such statistical significance may have little clinical relevance. Thus, it is critical that we specify treatment effects that correspond to clinically meaningful differences.
Sample size justification works the opposite way. Given a type I errorα , a pre-specified power β − 1 , and 0 H and a H , we want to find the smallest n such that the test has the given power to reject 0 H under a H
, : vs. :
vs. :
Although it is generally difficult to find an analytical formula for computing the smallest n satisfying (7), such an n is readily obtained by using statistical 
The above is often referred to as Cohen's d and is widely used in clinical research. In the example of distance, effect size is the same regardless of whether mile or kilometer is used.
Note that for simplicity, we have assumed that 
Sample Size for Two Independent Groups
Now consider two independent samples and let ij
) denote the random outcomes from the two samples. We assume that both group outcomes follow normal distributions, ) , (
Considering testing the hypothesis, Although most clinical trials allocate equal number of subjects into groups, some studies may assign more patients to a group . [4] We assume that the number of subjects in group 0 and group 1 are n 0 and n 1 , respectively. If
is true, the probability of rejecting H 0 , therefore committing type I errors, is readily calculated as: (11) where α is the type I error level set a priori and . In this case, the above arguments still apply, but the cumulative normal distribution Φ will be replaced by the cumulative t distribution to account for sampling variability when estimating 
Sample Size for Paired Groups
In the last section, data from the two groups are assumed independent. When groups are formed by different subjects, they are generally independent. In practice, we may be interested in changes before and after an intervention. For example, suppose we are interested in the effect of a newly developed drug on high blood pressure. We measure blood pressure of each subject before and after administering the drug and compare mean blood pressure between the two assessments. Since subjects with their blood pressure above the mean before the intervention are likely to stay above the mean blood pressure after the intervention, the two measures of blood pressure are not independent. As a result, the two independent group t-test does not apply to this paired group, or prepost study, setting. Let , then there is no treatment effect. In general, we are interested in testing the hypothesis (13)
In the two independent group case, j X 0 and k X 1 are assumed to have their own means and the hypothesis (12) involves both group means. In the current pairedgroup case, it is not necessary to identify the means of j X 0 and j X 1 , since only the mean of difference j D is of interest in the hypothesis (12). By comparing (4) and (13), it is readily seen that the sample size and power calculation is simply a special case of the one-group case with 0 :
Illustrations
In this section, we illustrate power and sample size calculations for the one group, two independent and two paired groups discussed using G*Power, a free program for power analysis, and R, a free package for statistical analysis, which also includes functions for power and sample size calculations for our current as well as more complex study settings. The statistical hypotheses is
We set α=0.05. Although the alternative shows an increased weight, we compute power under a two-sided test. To compute power, we first convert the parameters into effect size:
When using the G*Power package, choose the following options (see Figure 1) In R, we may use the pwr package to compute power. For t-tests, use the function:
pwr.t.test(n = , d = , sig.level = , power = , type = c("two.sample", "one.sample", "paired"))
where n is the sample size, d is the effect size, and type indicates a two-sample t-test, one-sample t-test or paired t-test. For each function, entering any three of the four quantities (effect size, sample size, significance level, power) and the fourth is calculated.
Using the function pwr.t.test (d = 0.5 , sig.level = 0.05 , power = 0.8 , type = "one.sample"), we obtain n = 33 after rounding to the nearest integer.
Example 2. A researcher, who wants to study the possible difference in hemoglobin between smokers 1 µ and non-smokers 0 µ , would be interested to find any mean differences The statistical hypothesis is Again, we set α=0.05 and compute power for a twosided test. Under the assumptions, the effect size is We also assume a common group size so that 
By viewing the paired-group setting as a special case of the one-group setting, we readily obtain sample size using the following options in G*Power (see Figure 3) (1 -β err prob) 0.80 From G*Power, we obtain n=52. Using the function pwr.t.test (d = 0.4 , sig.level = 0.05 , power = 0.8 , type = "paired") in R, we obtain n=51 after rounding to the nearest integer.
Conclusion
Sample size justification is an important consideration and a necessary component for clinical research studies. It provides critical information for assessing feasibility and clinical implications of such studies. Although power and sample size analysis relies on solid statistical theory and requires advanced computing methods, scientific investigators also play a critical role in this endeavor by providing relevant data. Without reliable input parameters, not only may power and sample size analysis be less informative, but more important potentially yield misleading information for study planning and execution.
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